COVID-19 vaccine Archives - Amazing Health Advances

COVID-19 Vaccine Shedding? New Research Concerns Over Menstrual Abnormalities

The AHA! Team — Mon, 17 Mar 2025 05:21:35 +0000

Lance D Johnson via Natural News – In the midst of the 15th-century Black Plague, a group of spice traders turned thieves defied the odds, robbing plague victims and their graves without succumbing to the deadly disease. Their secret? A potent blend of essential oils that protected them from infection. A new study links unvaccinated women near COVID-19-vaccinated individuals to menstrual irregularities, suggesting possible vaccine “shedding.” The study raises concerns about mRNA vaccine safety and the lack of pre-rollout shedding studies. Critics highlight censorship of women reporting menstrual changes and call for transparency in vaccine research. Researchers urge further investigation into vaccine component transmission and emphasize the need for informed consent. In a groundbreaking study published in the International Journal of Vaccine Theory, Practice, and Research, researchers uncovered a startling connection: Unvaccinated women who were in close proximity to individuals who received COVID-19 vaccines reported experiencing menstrual irregularities similar to those reported by vaccinated women. Unvaccinated women who were in close proximity to individuals who received COVID-19 vaccines reported experiencing menstrual irregularities similar to those reported by vaccinated women. The findings, which suggest the possibility of vaccine “shedding,” have reignited debates over the safety of mRNA vaccines and the Biden administration’s aggressive push for mass vaccination without adequate long-term testing. The study, led by researchers including Dr. Brian Hooker, Chief Scientific Officer of Children’s Health Defense (CHD), analyzed survey data from 3,390 unvaccinated women with no prior COVID-19 infection. Of these women, 85.5% reported being within six feet of a vaccinated person, and 71.7% experienced irregular menstrual symptoms within one week of exposure. The study’s authors noted that the timing and severity of these symptoms were statistically significant, raising questions about whether vaccine components could be transmitted from vaccinated to unvaccinated individuals. The study found that unvaccinated women who had daily close contact with vaccinated individuals outside their households were at the highest risk of menstrual irregularities, including heavier bleeding (34%), early period onset (28%), and extended bleeding (26%). Interestingly, women who lived with vaccinated partners or household members did not show the same increased risk, suggesting that environmental factors or prolonged exposure to larger groups of vaccinated individuals may play a role. Dr. Hooker emphasized that while the study does not definitively prove vaccine shedding, it provides compelling evidence that warrants further investigation. “This important study affirms that women exposed to individuals outside their household who received modified mRNA jabs for COVID-19 indeed experienced significantly higher levels of menstrual issues…” he told The Defender. Vaccine mandates and censorship put women at risk The study’s findings have reignited criticism of the Biden administration’s handling of the COVID-19 vaccine rollout. The administration and its allies on social media platforms actively silenced women who reported menstrual irregularities following vaccination. In 2021, a Facebook group with over 20,000 members sharing personal testimonies about menstrual changes was abruptly deleted, stifling crucial conversations about vaccine safety. Tiffany Parotto, founder of MyCycleStory and a co-author of the study, highlighted the importance of giving women a voice. “The need to research these occurrences and give a voice to the women who were silenced was obvious,” she wrote. The study also raises questions about the lack of pre-rollout shedding studies for mRNA vaccines. Nicolas Hulscher, an epidemiologist at the McCullough Foundation, pointed out that the FDA issued guidance for shedding studies in 2015 for gene therapies but failed to apply the same standards to COVID-19 vaccines. “Why didn’t our regulatory agencies conduct shedding studies before mass product rollout?” he asked. The study’s authors called for increased funding and research into the potential transmission of vaccine components, emphasizing the need for transparency and informed consent. Dr. Pierre Kory, president emeritus of the Front Line COVID-19 Critical Care Alliance, described the findings as “highly compelling” and urged regulatory agencies to take immediate action. Heather Ray, a science and research analyst with CHD, criticized the systemic gaslighting of women who reported adverse effects. “Over the past four years, women have continually been gaslighted, censored, and silenced by the media, the medical system, and government agencies regarding their experiences with the COVID-19 shot,” she said. The study’s findings underscore the need for a more cautious and transparent approach to vaccine development and distribution. While the Biden administration and social media platforms have dismissed concerns about menstrual irregularities, this research highlights the importance of listening to women’s experiences and conducting thorough safety studies before mandating experimental treatments. As the debate over vaccine safety continues, one thing is clear: women’s health should never be an afterthought. Sources for this article include: X.com ChildrensHealthDefense.org ChildrensHealthDefense.org To read the original article, click here

The post COVID-19 Vaccine Shedding? New Research Concerns Over Menstrual Abnormalities appeared first on Amazing Health Advances.

Kansas Sues Pfizer for Misleading the Public About the Risks of its mRNA COVID-19 Vaccines

The AHA! Team — Wed, 02 Oct 2024 08:06:39 +0000

Cassie B. via Natural News – The state of Kansas has filed a consumer protection lawsuit against the pharmaceutical company Pfizer, accusing it of misleading the public when it comes to both the safety and efficacy of its highly controversial mRNA COVID-19 vaccines. According to the suit, Pfizer knew that its vaccine came with significant adverse effects and manipulated its safety trials in order to deceive the public, violating Kansas’s consumer protection laws as well as previous consent judgments. The suit cites a slew of supporting evidence, including scientific and government research, press releases, interviews, and news reports demonstrating Pfizer’s misdeeds. According to the suit, Pfizer knew that its vaccine came with significant adverse effects and manipulated its safety trials For example, they cited a paper from the New England Journal of Medicine and an FDA memo to support the allegation that Pfizer purposely destroyed the control group of a COVID vaccine trial by providing participants with access to the jab. This made it impossible to fairly evaluate the safety of the vaccine by comparing a vaccinated group to one that was not vaccinated, the lawsuit alleges. In addition, they cited two articles from the British Medical Journal indicating that Pfizer delayed the release of vaccine trial data intentionally and only tested healthy patients in its vaccine trials in a marked departure from what is considered protocol. They cited two articles from the British Medical Journal indicating that Pfizer delayed the release of vaccine trial data intentionally To support their allegation that the company purposefully misrepresented the vaccine’s safety, they included press releases from Pfizer and interviews with CEO Albert Bourla in which the vaccine is presented as safe and effective. The lawsuit also refers to a Freedom of Information Act (FOIA) request filed by the watchdog group Public Health and Medical Professionals for Transparency in America with the FDA, through which they obtained information about the vaccine. From this FOIA suit, the group acquired an internal Pfizer database listing adverse events that was never shared with the public and contained far more incidents than those listed in the public-facing Vaccine Adverse Event Reporting System. In total, the internal database showed nearly 160,000 adverse events, along with more than 1,200 fatalities among the millions of people who received the vaccine as of February 2021. Heart problems and pregnancy complications weren’t disclosed to public The lawsuit also focused on specific health issues that have been coming to light since the vaccine rollout, such as heart problems. Not long after the vaccine started being administered to young people, it became apparent that it was having an adverse effect on their hearts, particularly young men. Myocarditis, which occurs when the middle layer of the heart’s wall becomes inflamed, can weaken the organ and has the potential to cause heart failure. The lawsuit alleges: “Pfizer said its COVID-19 vaccine was safe even though it knew its COVID-19 vaccine was connected to serious adverse events, including myocarditis and pericarditis, failed pregnancies, and deaths. Pfizer concealed this critical safety information from the public.” Another point of concern cited by the lawsuit is the dangers of the vaccine in pregnant women. It maintains that the company knew from a study that rat fetuses had trouble getting pregnant and implanting embryos and that their fetuses suffered malformations yet insisted to the public that the jab did not present any risk to pregnant women. The rat study was another revelation from the FOIA lawsuit, but the Kansas lawsuit also notes that Pfizer’s own data showed that tens of thousands of women experienced menstrual irregularities after getting the jab as of spring 2022. Kansas attorney general Kris Kobach told the National Review in an interview that the state’s Consumer Protection Act is designed to prevent consumers from being deceived by companies like Pfizer. “They had extraordinary success marketing their vaccine in the state of Kansas and more generally across the globe, and I think that had consumers had this information, many of them might have made a different choice,” he asserted. Sources for this article include: ArmageddonProse.Substack.com NationalReview.com To read the original article, click here: https://www.naturalnews.com/2024-09-20-kansas-sues-pfizer-misleading-public-risks-vaccines.html

The post Kansas Sues Pfizer for Misleading the Public About the Risks of its mRNA COVID-19 Vaccines appeared first on Amazing Health Advances.

CONFIRMED: COVID-19 Injections Alter Women’s Menstrual Cycle, Study Reveals

AHA Publisher — Mon, 29 Aug 2022 07:00:22 +0000

Sara Middleton via NaturalHealth365 – One of the earliest concerns raised over the COVID-19 shots from Pfizer and Moderna, which were manufactured and designed with genetic technology, was the possibility that these shots could disrupt human fertility. Part of this concern is based on research showing that the lipid nanoparticles containing mRNA from the jabs can travel around the body and interact with different organs, including the ovaries. Such concerns were quickly suppressed by mainstream media. But new survey data adds to the growing evidence showing that if not fertility directly, the shots CAN impact women’s health by altering their menstrual cycle. Nearly HALF of All Women Surveyed Suffered Changes to Their Menstrual Cycle Following COVID Shots A July 11, 2022 article posted on the website Science (title: “Thousands report unusual menstruation patterns after COVID-19 vaccination”) points to the concerning trend of menstrual cycle changes following COVID shots. They cite survey data based on an overall sample of 165,000 respondents. Reporting in Science Advances, after first making their paper available in February as a preprint, the survey researchers found that based on earlier data, nearly half (42 percent) of responding women bled more heavily than usual during their post-vax period. In another survey subset, two thirds of postmenopausal women reported breakthrough bleeding, as well as 40 percent of individuals undergoing gender-affirming hormone therapy. The authors conclude that “increased bleeding can occur post SARS-CoV-2 vaccines” while acknowledging that their sample may not be truly representative of the greater population and that the 42% statistic is much higher than other studies which have also also revealed menstrual irregularities post-jab. Despite the growing evidence that these shots may at least temporarily alter a woman’s period, the researchers, along with the covering Science article, continue to insist that the COVID shots overall have not been proven to negatively affect fertility. “Generally,” the authors write in their preprint, “changes to menstrual bleeding are not uncommon nor dangerous, yet attention to these experiences is necessary to build trust in medicine.” Indeed, some research, including a January 2022 prospective cohort study published in the Journal of American Epidemiology, suggests that infection with SARS-CoV-2 itself, as opposed to COVID-19 vaccination, may actually be associated with a short-term decline in male fertility. However, this is still a relatively nascent area of COVID vax research, and future investigative work is needed to give us more clarity over whether and how these shots may impact reproductive health. Especially since – as the Science article notes – “clinical trials of COVID-19 vaccines didn’t look for effects on the menstrual cycle.” If Not the Shot … Here Are Seven Other Things That Can Impact a Woman’s Menstrual Cycle As a woman, your menstrual cycle can offer good clues to your hormonal balance and overall health and wellness. Menstrual irregularities “usually aren’t serious,” Mayo Clinic says, but they can “sometimes signal health problems.” Here are seven possible causes of abnormal periods, in addition to vaxxes, pregnancy, and breastfeeding: Eating disorders (e.g., anorexia nervosa) Extreme weight loss Excessive exercise Polycystic ovary syndrome (PCOS) Premature ovarian failure (also known as primary ovarian insufficiency, this refers to the loss of normal ovarian function before age 40) Pelvic inflammatory disease (PID), which is a potentially life-threatening infection of the reproductive organs Uterine fibroids (non-cancerous growths in the uterus), which can cause heavy and/or prolonged periods If you have any concerns about your menstrual cycle, talk to a trusted healthcare provider. Sources for this article include: Mayoclinic.org Medrxiv.org News.com.au NIH.gov NIH.gov Science.org To read the original article click here.

The post CONFIRMED: COVID-19 Injections Alter Women’s Menstrual Cycle, Study Reveals appeared first on Amazing Health Advances.

FDA Restricts Use of Johnson & Johnson COVID Vaccine Due to Rare but Serious Blood Clot Risk

AHA Publisher — Mon, 09 May 2022 07:00:56 +0000

News Staff via CBN News – The U.S. government has put strict limitations on the Johnson & Johnson COVID vaccine because of a serious health risk. Regulators took that action because of the ongoing possibility of rare, but serious, blood clots. The Food and Drug Administration (FDA) said the shot should only be given to adults who can’t get any other vaccine or specifically request the one from Johnson and Johnson. U.S. authorities for months have recommended that Americans get Pfizer or Moderna shots instead of the J&J vaccine. FDA vaccine chief Dr. Peter Marks said the agency decided to restrict the vaccine after taking another look at the data on the risks of life-threatening blood clots and concluding that they are limited to J&J’s vaccine. “If there’s an alternative that appears to be equally effective in preventing severe outcomes from COVID-19, we’d rather see people opting for that,” Marks said. “But we’ve been careful to say that – compared to no vaccine – this is still a better option.” The problem occurs in the first two weeks after vaccination. So if you got a Johnson & Johnson shot a while ago, and haven’t had problems with blood clots, experts say you can rest easy. CDC Recommended Other Shots As CBN News reported last December, the Centers for Disease Control and Prevention recommended Moderna and Pfizer shots over J&J’s because of the rare blood clotting condition. At that time, the strange clotting problem caused nine confirmed deaths after J&J vaccinations. As of mid-March, federal scientists had identified 60 cases of the side effect, including nine that were fatal. That amounts to 3.23 blood clot cases per 1 million J&J shots. The problem is more common in women under 50, where the death rate was roughly 1 per million shots, according to Marks. Marks said the FDA spent extra time analyzing the problem to be sure it wasn’t connected to a separate issue, such as women taking birth control medications that raise their risk of clotting. The J&J vaccine will carry a starker warning about the potential “long-term and debilitating health consequences” of the side effect. A J&J spokesman said in an emailed statement: “Data continue to support a favorable benefit-risk profile for the Johnson & Johnson COVID-19 vaccine in adults when compared with no vaccine.” FDA Authorized J&J Shot in February 2021 The Johnson & Johnson vaccine was first authorized by the FDA in February of 2021 for emergency use for adults 18 and up. It was the first single-shot vaccine in the fight against the global pandemic. The vaccine was initially considered an important tool in fighting the pandemic because it required only one shot. But the single-dose option proved less effective than two doses of the Pfizer and Moderna vaccines. The rollout of the company’s vaccine was hurt by a series of troubles, including manufacturing problems at a Baltimore factory that forced J&J to import millions of doses from overseas. However, clotting problems first came up last spring, with the J&J shot in the U.S. and with a similar vaccine made by AstraZeneca that is used in other countries. At that time, U.S. regulators decided the benefits of J&J’s one-and-done vaccine outweighed what was considered a very rare risk — as long as recipients were warned. Potentially Dangerous Neurological Reaction to Shot Reported Last July As CBN News reported in July of 2021, regulators added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it was not entirely clear the shot caused the problem. The FDA announced the warning, flagging reports of Guillain-Barre syndrome, an immune system disorder that can cause muscle weakness and occasionally paralysis. Health officials described the side effect as a “small possible risk” for those getting the shot. The action came after the FDA and the CDC reviewed reports of about 100 people developing the syndrome after receiving the one-dose vaccine. Almost all of were hospitalized and one person died, the FDA said. To read the original article click here.

The post FDA Restricts Use of Johnson & Johnson COVID Vaccine Due to Rare but Serious Blood Clot Risk appeared first on Amazing Health Advances.

Pfizer to Seek Approval for COVID Vaccine ‘Within Days’

AHA Publisher — Fri, 20 Nov 2020 08:00:11 +0000

Tré Goins-Phillips, Faithwire via CBN News – The pharmaceutical giant Pfizer announced Wednesday it will seek regulatory approval for its COVID-19 vaccine “within days.” Working in partnership with the German group BioNTech, Pfizer has completed its Phase 3 trial and has deemed the vaccination 95% effective at preventing COVID-19 infections, NBC News reported, up from 90% last week. Former Food and Drug Administration Commissioner Dr. Scott Gottlieb, who serves as an independent member on Pfizer’s board of directors, described the development as a “game change,” adding the successes in vaccine development “could effectively end the U.S. epidemic next year.” To date, there have been no serious side effects for the 41,135 adults who received two doses of the Pfizer vaccine. The most common reaction among trial participants were that 3.7% experienced fatigue and 2% had headaches. Only eight of those who received the Pfizer vaccination fell ill to COVID-19. By comparison, 162 of those who received the placebo became sick. “The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic,” Pfizer Chairman and CEO Dr. Albert Bourla said in a statement. “With hundreds of thousands of people around the globe infected every day, we urgently need to get a safe and effective vaccine to the world.” The companies — Pfizer and BioNTech — announced their joint plan to seek emergency use authorization from the FDA “within days.” The groups are also sharing their findings with regulators in Europe. Pfizer’s data shows the vaccination 95% effective against future infections beginning 28 days after the first two doses. The immunization’s effectiveness was found to be consistent across all age and race demographics. Furthermore, its side effects wore off “shortly after vaccination,” and among older adults, they tended to be “fewer and milder.” News of Pfizer’s rapidly evolving vaccine comes just a couple days after the biotech company Moderna announced its COVID-19 vaccine is 94.5% effective against infection. Moderna President Dr. Stephen Hogue described the development as a “really important milestone,” adding he’s reassured by the fact that Pfizer has released similar findings. “That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” he added. Both the Moderna and Pfizer vaccines were developed using messenger RNA, tiny pieces of genetic code injected into the body to trick the immune system into producing a response to fend off COVID-19 without actually having to inject actual bits of the virus. Anything Else? This week, CNN’s Jake Tapper and Dr. Sanjay Gupta praised President Donald Trump’s administration for its work to facilitate the production of a COVID-19 vaccine at breakneck speed. “It’s important that people working so hard — Monsef Slaoui and the others — get credit for this, and President Trump was the one who OK’d it,” Tapper said. Gupta agreed, adding, “No doubt. The pace of medical innovation has been forever changed. I mean, three months, Jan. 11 is when they got the sequence of this virus. By March 16, two months later, shots were going into arms as part of these clinical trials. I couldn’t believe it when I saw that pace. It typically takes, you know, years to really get these vaccines approved. It’ll be done within a year. That is worth celebrating, and now we have some early data to be very optimistic about.” “So all of the scientists, everyone behind this, all the way up to President Trump and Vice President Pence, congratulations on this great accomplishment,” said Tapper. Trump, for his part, thanked Tapper and Gupta for their comments. To read the original article click here. For more articles from CBN News click here.

The post Pfizer to Seek Approval for COVID Vaccine ‘Within Days’ appeared first on Amazing Health Advances.

Israel to Begin Clinical Trials of Covid-19 Vaccine

AHA Publisher — Tue, 27 Oct 2020 07:00:19 +0000

Abigail Klein Leichman via Israel21c – The governmental Israel Institute for Biological Research (IIBR) has approval from the Ministry of Health and the Helsinki Committee to begin testing its vaccine, BriLife, against the SARS-CoV-2 coronavirus on November 1. The IIBR has prepared 25,000 doses of BriLife and has recruited the first volunteers in an 80-person clinical trial, 40 at Hadassah University Medical Center in Jerusalem and 40 at Sheba Medical Center in Ramat Gan. Each volunteer, aged 18 to 55, will receive an injection (vaccine or placebo). After a few hours of supervision he/she will be discharged and monitored for three weeks for any possible side effects and for the development of antibodies to the virus in response to the vaccine. The second phase will include extensive safety tests on 960 healthy volunteers, to begin in December in several medical centers across Israel. In this phase, scientists aim to complete vaccine safety precautions, determine effective dosage, and further determine the vaccine’s effectiveness. The third and final phase is a large-scale trial to test the effectiveness of BriLife, with the participation of up to 30,000 volunteers. Subject to the success of the first two phases, this phase is scheduled to begin in April or May. If it is successful, the vaccine may be approved for mass use. On June 21, ISRAEL21c reported that a single dose of the IIBR’s recombinant VSV-∆G-spike vaccine “results in rapid and potent induction of neutralizing antibodies against SARS-CoV-2” in Syrian golden hamsters in a successful preclinical trial. It was also tested successfully in mice, rabbits and pigs, paving the way to human trials. “Our final goal is 15 million doses for the residents of the State of Israel and for our close neighbors,” said Prof. Shmuel Shapira, director of the IIBR. The research institute in Ness Ziona, which is part of the Ministry of Defense, has been directing all its efforts in the past few months toward novel coronavirus research. In collaboration with several partners, the IIBR also is developing an antibody-based Covid-19 treatment and a new method to detect the virus through breath analysis. Shapira said the name BriLife puts together the Hebrew word for health, briut, with “il” for Israel and “life” — which speaks to the importance of the vaccine. To read the original article click here. For more articles from Israel21c click here.

The post Israel to Begin Clinical Trials of Covid-19 Vaccine appeared first on Amazing Health Advances.

Promising COVID-19 Vaccine Trial on Hold – Setback or Standard Procedure?

AHA Publisher — Fri, 11 Sep 2020 07:00:44 +0000

News Staff via CBN News – There’s been a potential setback in efforts to pursue a COVID-19 vaccine as one of the most promising trials has now been placed on hold. Researchers are pausing the stage three vaccine trial being conducted by Oxford University in the UK after a volunteer came down with an unexplained illness. AstraZeneca, the company developing that vaccine with Oxford, is conducting an investigation to determine if the illness is linked to the trial. In a statement, the company insisted that they won’t seek approval or emergency use until “demonstrating safety and efficacy through a phase 3 clinical study. “The safety and efficacy of vaccines, including any potential vaccine for COVID-19, is reviewed and determined by expert regulatory agencies around the world, such as the United States Food and Drug Administration (FDA)” the statement reads. “FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US.” Chief executives of nine drug companies, including AstraZeneca, BioNTech, Moderna, Pfizer, Novavax, Sanofi, GlaxoSmithKline, Johnson & Johnson, and Merck vowed not to rush a vaccine. The pledge is intended to “help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved.” Scientists are evaluating the public health impact of rushing a vaccine and the potential safety concerns, against the effect of delaying this highly anticipated treatment. But, they point out that temporary halts are common in vaccine trials. Meanwhile, two other vaccines are in stage-three trials in the US. Just this week, President Trump said there could be a vaccine before Election Day. “So, we’re going to have a vaccine very soon. Maybe even before a very special date,” he stated. To read the original article click here. For more articles from CBN News click here.

The post Promising COVID-19 Vaccine Trial on Hold – Setback or Standard Procedure? appeared first on Amazing Health Advances.